In a pilot trial of NAD+ intravenous infusion in healthy adults, subjects receiving 750 mg of NAD+ over 6 hours reported no negative symptoms at all, and there were no vital sign abnormalities or serious laboratory derangements compared to placebo
Choline, inositol, and methionine are discussed in relation to methyl-donor balance, membrane biology, and nutrient metabolism
Important considerations: BPC-157 is sold for research purposes only and is not intended for human consumption No human clinical trials have established safety or efficacy Quality and purity of research peptides vary significantly between suppliers Individual responses may differ significantly from research findings Always consult with a qualified healthcare provider before considering any peptide research This content does not constitute medical advice, diagnosis, or treatment recommendations The decision to use any research compound is a personal one that should be made with full awareness of the legal status, limited human data, and potential risks involved
The nausea and vomiting was worse in the beginning weeks and slowly got better
Many people meet their B12 needs through food alone
What preventive measures must be taken for safe administration
